2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on NSCLC: Neoadjuvant Chemo for Locally Advanced Disease, Gefitinib vs Chemo for EGFR+ NSCLC & Adjuvant Osimertinib ‘Practice Changing’ for Early-Stage EGFR Mutated NSCLC
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Nagashree Seetharamu
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Nagashree Seetharamu
Login to view comments.
Click here to Login
